Intervention not reported
Outpatient care · low‐income/general population
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Outpatient care · general population
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Admissions (outpatients) · children with acute bronchiolitis
2 findings from 1 review
Admissions (outpatients) · children with acute bronchiolitis
2 findings from 1 review
Admissions at enrollment or < 24 hours (outpatients only) · patients with acute viral bronchiolitis
Epinephrine probably leads to lower admissions at enrollment or < 24 hours (outpatients only) compared with placebo (moderate certainty).
1 finding from 1 review
Admissions overall up to 7 days (outpatients only) · patients with acute viral bronchiolitis
Epinephrine showed no clear difference in admissions overall up to 7 days (outpatients only) compared with steroid (moderate certainty).
1 finding from 1 review
Admissions overall up to 7 days (outpatients only) · patients with acute viral bronchiolitis
Epinephrine showed no clear difference in admissions overall up to 7 days (outpatients only) compared with placebo (low certainty).
1 finding from 1 review
Admissions at enrollment or < 24 hours (outpatients only) · patients with acute viral bronchiolitis
Epinephrine showed no clear difference in admissions at enrollment or < 24 hours (outpatients only) compared with salbutamol/albuterol (moderate certainty).
1 finding from 1 review
Admissions overall up to 7 days (outpatients only) · patients with acute viral bronchiolitis
Epinephrine showed no clear difference in admissions overall up to 7 days (outpatients only) compared with salbutamol/albuterol (moderate certainty).
1 finding from 1 review
Admissions at enrollment or < 24 hours (outpatients only) · patients with acute viral bronchiolitis
Epinephrine and steroid showed no clear difference in admissions at enrollment or < 24 hours (outpatients only) compared with placebo (low certainty).
1 finding from 1 review
Admissions overall up to 7 days (outpatients only) · patients with acute viral bronchiolitis
Epinephrine and steroid may leads to lower admissions overall up to 7 days (outpatients only) compared with placebo (low certainty).
1 finding from 1 review
Admissions (outpatients) · patients with acute viral bronchiolitis
Epinephrine showed no clear difference in admissions (outpatients only) compared with steroid (moderate certainty).
1 finding from 1 review
Mortality outpatient · patients with colorectal surgery
Primary analyses ERAS showed no clear difference in mortality outpatient compared with conventional (high certainty).
1 finding from 1 review
Tolerability of the procedure · women undergoing outpatient hysteroscopy
1 finding from 1 review
Adverse events and complications · women undergoing outpatient hysteroscopy
Saline probably leads to lower adverse events and complications compared with carbon dioxide (moderate certainty).
1 finding from 1 review
Quality of hysteroscopic view · women undergoing outpatient hysteroscopy
Saline may leads to lower quality of hysteroscopic view compared with carbon dioxide (low certainty).
1 finding from 1 review
Duration of the procedureassessed in seconds · women undergoing outpatient hysteroscopy
1 finding from 1 review
Tolerability of the procedure · women undergoing outpatient hysteroscopy
1 finding from 1 review
Adverse events and complications · women undergoing outpatient hysteroscopy
1 finding from 1 review
Quality of hysteroscopic view · women undergoing outpatient hysteroscopy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found